Comparable stake leader
Damon DeSantis
SEC ownership of INTEGRATED BIOPHARMA INC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001016504.
Disclosed value leader
Damon DeSantis
Comparable rows
0/9
Latest evidence
24 Jun 2026
- Public ticker
- INBP on OTC
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Damon DeSantis
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
24 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001016504
- Issuer location
- Hillside, NJ
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of INTEGRATED BIOPHARMA INC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Damon DeSantis
Disclosed value leader
Damon DeSantis
Comparable rows
0/9
Latest evidence
24 Jun 2026
3/4/5
Highest disclosed value: $3,692,586
9 rows are not safely comparable across share classes.
Showing 1-8 of 9 holder rows.
Quick read
Damon DeSantis has the largest disclosed position value at $3.69M.
0 of 9 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Damon DeSantis's linked filing trail.
Disclosed position value
Top 5
Damon DeSantis
$3.69M
Gerald Kay Estate Edward
$1.12M
Christina Kay
$132.6K
Sheppard Riva
$132.6K
William H. Milmoe
$728.7K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-8 of 9 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Damon DeSantis |
3/4/5
Director, 10%+ Owner
|
—
mixed-class rows
|
$3,692,586
12,783,058 shares
mixed-class rows
|
— | 24 Jun 2026 |
| Gerald Kay Estate Edward |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$1,119,897
3,293,815 shares
|
— | 20 Mar 2023 |
| Christina Kay |
3/4/5
Co-Chief Executive Officer, Director, 10%+ Owner
|
—
mixed-class rows
|
$132,612
1,613,467 shares
mixed-class rows
|
— | 09 Dec 2025 |
| Sheppard Riva |
3/4/5
Co-Chief Executive Officer, 10%+ Owner
|
—
mixed-class rows
|
$132,612
1,613,467 shares
mixed-class rows
|
— | 09 Dec 2025 |
| Carl Desantis |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
50,000 shares
|
— | 15 Apr 2026 |
| William H. Milmoe |
3/4/5
Director
|
—
mixed-class rows
|
$728,697
2,562,751 shares
mixed-class rows
|
— | 24 Jun 2026 |
| Dina L. Masi |
3/4/5
Chief Financial Officer
|
—
mixed-class rows
|
$31,248
487,200 shares
mixed-class rows
|
— | 09 Dec 2025 |
| Robert Canarick |
3/4/5
Director
|
—
mixed-class rows
|
$21,080
284,233 shares
mixed-class rows
|
— | 24 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 09 Jul 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-10 of 10 reporting-owner rows connected to INTEGRATED BIOPHARMA INC. Open a relationship link for the CIK-to-CIK filing trail.
Rows
10
Largest Forms 3/4/5 holder
Damon DeSantis
Net 12M change
$0
Latest report
24 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Damon DeSantis | Director, 10%+ Owner | $3,692,586 | Median | 24 Jun 2026 | ||
| Gerald Kay Estate Edward | 10%+ Owner | $1,119,897 | Mixed | 20 Mar 2023 | ||
| William H. Milmoe | Director | $728,697 | Median | 24 Jun 2026 | ||
| Sheppard Riva | Co-Chief Executive Officer, 10%+ Owner | $132,612 | Mixed | 09 Dec 2025 | ||
| Christina Kay | Co-Chief Executive Officer, Director, 10%+ Owner | $132,612 | Mixed | 09 Dec 2025 | ||
| Dina L. Masi | Chief Financial Officer | $31,248 | Mixed | 09 Dec 2025 | ||
| Robert Canarick | Director | $21,080 | Mixed | 24 Jun 2026 | ||
| Carl Desantis | 10%+ Owner | $0 | Mixed | 15 Apr 2026 | ||
| E. Gerald Kay | Executive Chairman & President, Director, 10%+ Owner | Mixed | 30 Jun 2023 | |||
| Eric J. Friedman | Director | Mixed | 24 Jun 2026 |
Recent insider transactions for INTEGRATED BIOPHARMA INC
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Eric J. Friedman | INBP | Stock Option (Right to Buy) | Award | 50,000 | 50,000 | 24 Jun 2026 | Direct | |||
| Damon DeSantis | INBP | Stock Option (Right to Buy) | Award | 50,000 | 50,000 | 24 Jun 2026 | Direct | |||
| Eric J. Friedman | INBP | Stock Option (Right to Buy) | Award | 50,000 | 50 | 24 Jun 2026 | Direct | |||
| Robert Canarick | INBP | Stock Option (Right to Buy) | Award | 50,000 | 50,000 | 24 Jun 2026 | Direct | |||
| William H. Milmoe | INBP | Stock Option (Right to Buy) | Award | 50,000 | 50,000 | 24 Jun 2026 | Direct | |||
| William H. Milmoe | INBP | Common Stock | Gift | -94.2% | -2,235,417 | 138,667 | 15 Apr 2026 | Direct | ||
| William H. Milmoe | INBP | Common Stock | Gift | -79.1% | -8,966,547 | 2,374,084 | 15 Apr 2026 | Trustee or Officer | ||
| William H. Milmoe | INBP | Common Stock | Gift | -94.2% | -2,235,417 | 138,667 | 15 Apr 2026 | Direct | ||
| William H. Milmoe | INBP | Common Stock | Gift | -79.1% | -8,966,547 | 2,374,084 | 15 Apr 2026 | Trustee or Officer | ||
| Carl Desantis | INBP | Common Stock | Gift | -100% | -11,201,964 | 0 | 15 Apr 2026 | Reporting Person is deceased | ||
| Damon DeSantis | INBP | Common Stock | Gift | 731.6% | 11,201,964 | 12,733,058 | 15 Apr 2026 | By CDDS 2.0, LLC | ||
| Carl Desantis | INBP | Common Stock | Gift | -10.7% | -1,363,685 | 11,366,673 | 24 Mar 2026 | Reporting Person is deceased | ||
| William H. Milmoe | INBP | Common Stock | Gift | -10.6% | -1,363,685 | 11,505,340 | 24 Mar 2026 | Trustee or Officer | ||
| Damon DeSantis | INBP | Common Stock | Gift | 1,363,685 | 1,363,685 | 24 Mar 2026 | By CDDS 2.0, LLC | |||
| Christina Kay | INBP | Stock Option (Right to Buy) | Award | 140,000 | 140,000 | 09 Dec 2025 | Direct | |||
| Sheppard Riva | INBP | Stock Option (Right to Buy) | Award | 140,000 | 140,000 | 09 Dec 2025 | Direct | |||
| Dina L. Masi | INBP | Stock Option (Right to Buy) | Award | 140,000 | 140,000 | 09 Dec 2025 | Direct |
* marks a reported price that did not pass the local price check.